Sonoma Pharmaceuticals Inc. sell blaugold
Start price
25.01.23
/
50%
€2.18
Target price
25.01.24
-
Performance (%)
-59.32%
End price
29.05.23
€0.89
Summary
This prediction ended on 29.05.23 with a price of €0.89. blaugold correctly predicted massive losses of -59.32% for Sonoma Pharmaceuticals Inc.. blaugold has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sonoma Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % | 52,75 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % | 88,39 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % | 59,41 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % | 60,39 % |
According to blaugold what are the pros and cons of Sonoma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by blaugold for this prediction
In the thread Sonoma Pharmaceuticals, Inc. diskutieren
Sell Sonoma Pharmaceuticals Inc.